C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase

Details for Australian Patent Application No. 2005254057 (hide)

Owner Isis Pharmaceuticals, Inc. Merck Sharp & Dohme Corp.

Inventors MacCoss, Malcolm; Bhat, Balkrishen; Eldrup, Anne B.; Butora, Gabor

Agent Spruson & Ferguson

Pub. Number AU-B-2005254057

PCT Pub. Number WO2005/123087

Priority 60/663,009 18.03.05 US; 60/579,823 15.06.04 US

Filing date 10 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 17 February 2011

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/522 (2006.01)

A61K 31/70 (2006.01) - Carbohydrates

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123087 Priority application(s): WO2005/123087

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Isis Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp.

17 February 2011 Application Accepted

  Published as AU-B-2005254057

16 June 2011 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Isis Pharmaceuticals, Inc.; Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254058-Use of VEGF inhibitors for the treatment of human cancer

2005254055-Topical compositions containing 5'-adenosine-diphosphate ribose